May 28, 2020
As per the report titled ‘Dermal Filler Market Size By Type, By Material Type, By Application, By End-use, Industry Analysis Report, Regional Outlook, Application Potential, Competitive Market Share & Forecast, 2020 - 2026’, available with Market Study Report LLC, global dermal filler market is expected to record a healthy growth rate during 2020-2026.
Growing demand for cosmetic surgeries for improving appearance is the primary growth driver of global dermal filler market. Dermal fillers are small injections filled with gel made up of hylauronic acid that is capable of reducing facial lines and restoring fullness and volume of the face.
Dermal fillers can be injected in several parts of the face including mouth, jawline, cheeks, eye, and lips. These fillers are administered directly into the skin or lip tissues. Rising patient inclination towards minimally invasive procedures is also contributing to the market growth.
These fillers are used for various procedures such as plumping lips, improving appearance of recessed scars, reducing shadow of lower lids, reconstructing contour defects in face, and reducing facial creases & wrinkles. Moreover, these procedures are an enhanced part of cosmetic facial rejuvenation surgery and will see a high demand from patients with early symptoms of aging, thereby stimulating the market outlook.
Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/1434128/
Based on type, semi-permanent biodegradable segment is expected to accrue significant gains by the end of the forecast period. The growth can be credited to wide-spread use of these fillers in treating nasolabial folds & deeper scars. They are also use used for plumping thin lips, enhancing jawline & cheekbones, and treating facial wasting caused by HIV medications. Long-lasting results are boosting the demand for semi-permanent biodegradable dermal fillers.
With respect to the material terrain, poly-l-lactic acid (PPLA) segment is projected to see rapid growth over 2020-2026, owing to the recent approval by U.S. FDA for using PPLA as a filler for treating facial lipoatrophy in HIV patients. PPLA reduces facial lines and builds volume by aiding the skin in rebuilding its natural collagen. Benefits such as revolumization, increased thickness, and minimal safety concerns will augment the demand for PPLA in the ensuing years.
Elaborating on the application scope, facial fillers segment is expanding at an unprecedented rate. The ability to smoothen frown lines between eyebrows, nasolabial folds & skin, and other facial lines is fueling the demand for facial fillers.
Speaking of the end-use spectrum, dermal filler market share from hospitals is estimated to record a considerable growth over the forecast timeline. Availability of high-quality services, skilled plastic surgeons, and advanced infrastructure is encouraging consumers to opt for hospitals.
As per the regional analysis, Latin America dermal filler market is slated to record a strong growth through 2026, with Brazil dethroning U.S as the location with highest number of cosmetic surgeries performed across the globe. Upsurge in demand for cosmetic procedures owing to growing self-consciousness among the population and lower treatment costs as compared to U.S. is supporting the regional market expansion.
Key players operating in global dermal filler market are Teoxane S.A., Merz Aesthetics, Allergan plc, Galderma S.A., Prollenium Medical Technologies, Inc., Suneva Medical, Syneron Medical, Shanghai Bioha Technology Co., Ltd., Cytophil, Inc., BIOHA Laboratories, Hangzhou Gallop Biological Products Co., Ltd., Croma Pharma GmbH, and Huons, Co.